{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:32:15Z","timestamp":1794097935106,"version":"4.8.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.idc.2018.10.005","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T02:50:12Z","timestamp":1548989412000},"page":"79-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"title":["Visceral Leishmaniasis"],"prefix":"10.1016","volume":"33","author":[{"given":"Johan","family":"van Griensven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias","family":"Diro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.idc.2018.10.005_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1473-3099(14)70833-3","article-title":"Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings","volume":"15","author":"Diro","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trstmh.2010.09.006","article-title":"Diagnosis of visceral leishmaniasis","volume":"105","author":"Srivastava","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib6","first-page":"107","article-title":"Visceral leishmaniasis in Sudan. Clinical features","volume":"42","author":"Siddig","year":"1990","journal-title":"Trop Geogr Med"},{"issue":"5","key":"10.1016\/j.idc.2018.10.005_bib7","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JCM.01733-09","article-title":"Evaluation of blood agar microtiter plates for culturing leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis","volume":"48","author":"Maurya","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4269\/ajtmh.16-0362","article-title":"Diagnosis of visceral leishmaniasis using peripheral blood microscopy in Ethiopia: a prospective phase-III study of the diagnostic performance of different concentration techniques compared to tissue aspiration","volume":"96","author":"Diro","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.idc.2018.10.005_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.actatropica.2007.04.015","article-title":"A\u00a0microculture technique for isolating live Leishmania parasites from peripheral blood of visceral leishmaniasis patients","volume":"102","author":"Hide","year":"2007","journal-title":"Acta Trop"},{"issue":"5","key":"10.1016\/j.idc.2018.10.005_bib10","first-page":"951","article-title":"Laboratory diagnosis of visceral leishmaniasis","volume":"9","author":"Sundar","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"96","author":"Aronson","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.idc.2018.10.005_bib12","doi-asserted-by":"crossref","first-page":"e0006277","DOI":"10.1371\/journal.pntd.0006277","article-title":"Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain","volume":"12","author":"Bangert","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trstmh.2010.09.004","article-title":"Multi-centric prospective evaluation of rk39 rapid test and direct agglutination test for the diagnosis of visceral leishmaniasis in Brazil","volume":"105","author":"de Assis","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.trstmh.2007.11.004","article-title":"Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis","volume":"102","author":"Pedras","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"14","key":"10.1016\/j.idc.2018.10.005_bib15","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1017\/S0031182017001378","article-title":"Multicentre evaluation of a direct agglutination test prototype kit (DAT-LPC) for diagnosis of visceral leishmaniasis","volume":"144","author":"Oliveira","year":"2017","journal-title":"Parasitology"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1073\/pnas.90.2.775","article-title":"Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis","volume":"90","author":"Burns","year":"1993","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.1016\/j.idc.2018.10.005_bib17","article-title":"Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease","author":"Boelaert","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.idc.2018.10.005_bib18","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/cis716","article-title":"A\u00a0global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis","volume":"55","author":"Cunningham","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2018.10.005_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/trstmh\/trv060","article-title":"Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan","volume":"109","author":"Mukhtar","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.idc.2018.10.005_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000822","article-title":"Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis","volume":"4","author":"Pattabhi","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.idc.2018.10.005_bib21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4269\/ajtmh.13-0759","article-title":"Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients","volume":"91","author":"Bezuneh","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib22","doi-asserted-by":"crossref","first-page":"e0006264","DOI":"10.1371\/journal.pntd.0006264","article-title":"Sensitive and less invasive confirmatory diagnosis of visceral leishmaniasis in Sudan using loop-mediated isothermal amplification (LAMP)","volume":"12","author":"Mukhtar","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00436-017-5716-3","article-title":"Performance of two immunochromatographic tests for diagnosis of visceral leishmaniasis in patients coinfected with HIV","volume":"117","author":"da Silva","year":"2018","journal-title":"Parasitol Res"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib24","first-page":"39","article-title":"Non invasive diagnostic tools for visceral leishmaniasis: a comparison of the immunoserological tests DAT, rK26 and rK39","volume":"30","author":"Teran-Angel","year":"2010","journal-title":"Biomedica"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000083915","article-title":"Cross-reaction of sera from patients with various infectious diseases with Leishmania infantum","volume":"14","author":"Kohanteb","year":"2005","journal-title":"Med Princ Pract"},{"issue":"3","key":"10.1016\/j.idc.2018.10.005_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0035-9203(93)90125-A","article-title":"Evaluation of the direct agglutination test as an immunodiagnostic tool for kala-azar in India","volume":"87","author":"Singla","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.idc.2018.10.005_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.trstmh.2005.08.018","article-title":"Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test","volume":"100","author":"Sundar","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2018.10.005_bib28","unstructured":"Vogt F, Mengesha B, Asmamaw H, et\u00a0al. Accuracy of antigen detection in urine using KATex for non-invasive visceral leishmaniasis diagnosis and treatment monitoring in HIV-coinfected patients. 2017. Available at: http:\/\/www.itg.be\/Files\/ECTMIH\/ECTMIH%20final_programme.pdf. Accessed June 1, 2018."},{"issue":"12","key":"10.1016\/j.idc.2018.10.005_bib29","first-page":"899","article-title":"Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up","volume":"23","author":"Riera","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2018.10.005_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12879-015-1125-3","article-title":"Development and comparative evaluation of two antigen detection tests for visceral leishmaniasis","volume":"15","author":"Vallur","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2018.10.005_bib31","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JCM.00372-14","article-title":"Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy","volume":"52","author":"de Ruiter","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12879-017-2318-8","article-title":"Development of a rapid loop-mediated isothermal amplification assay for diagnosis and assessment of cure of Leishmania infection","volume":"17","author":"Verma","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2018.10.005_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00386-18","article-title":"Development and evaluation of a novel LAMP assay for the diagnosis of cutaneous and visceral leishmaniasis","volume":"56","author":"Adams","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2018.10.005_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.idc.2018.10.005_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4269\/ajtmh.13-0239","article-title":"Comparison of parasitological, serological, and molecular tests for visceral leishmaniasis in HIV-infected patients: a cross-sectional delayed-type study","volume":"89","author":"Cota","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.idc.2018.10.005_bib36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4269\/ajtmh.2009.80.929","article-title":"Field evaluation of rK39 test and direct agglutination test for diagnosis of visceral leishmaniasis in a population with high prevalence of human immunodeficiency virus in Ethiopia","volume":"80","author":"ter Horst","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.idc.2018.10.005_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(08)70043-4","article-title":"Leishmaniasis among organ transplant recipients","volume":"8","author":"Antinori","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2018.10.005_bib38","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pntd.0001665","article-title":"The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis","volume":"6","author":"Cota","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4269\/ajtmh.12-0527","article-title":"Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-infected patients","volume":"89","author":"Molina","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2018.10.005_bib40","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0035-9203(02)90074-X","article-title":"A\u00a0nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus","volume":"96","author":"Cruz","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.idc.2018.10.005_bib41","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1468-1293.2010.00846.x","article-title":"\u2018Active chronic visceral leishmaniasis\u2019 in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients","volume":"11","author":"Bourgeois","year":"2010","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"(ASTMH) IDSoAIatASoTMaH. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"96","author":"Aronson","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib43","doi-asserted-by":"crossref","first-page":"e2603","DOI":"10.1371\/journal.pntd.0002603","article-title":"Five-year field results and long-term effectiveness of 20\u00a0mg\/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India","volume":"8","author":"Burza","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.idc.2018.10.005_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib45","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/AAC.00840-13","article-title":"Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment","volume":"58","author":"Di Masi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib46","doi-asserted-by":"crossref","first-page":"e2613","DOI":"10.1371\/journal.pntd.0002613","article-title":"Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial","volume":"8","author":"Khalil","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib47","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s12879-016-1746-1","article-title":"Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia","volume":"16","author":"Tamiru","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2018.10.005_bib48","doi-asserted-by":"crossref","first-page":"e0005706","DOI":"10.1371\/journal.pntd.0005706","article-title":"Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: a multicenter, randomized, open label trial","volume":"11","author":"Romero","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.idc.2018.10.005_bib49","doi-asserted-by":"crossref","first-page":"e1674","DOI":"10.1371\/journal.pntd.0001674","article-title":"Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial","volume":"6","author":"Musa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.idc.2018.10.005_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40261-016-0481-0","article-title":"Safety and effectiveness of sodium stibogluconate and paromomycin combination for the treatment of visceral leishmaniasis in Eastern Africa: results from a pharmacovigilance programme","volume":"37","author":"Kimutai","year":"2017","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.idc.2018.10.005_bib51","unstructured":"WHO. Control of the leishmaniasis. Report of a meeting of the WHO expert committee on the control of leishmaniases. WHO technical report series 9492010, Geneva, 22\u201326 March 2010."},{"issue":"9764","key":"10.1016\/j.idc.2018.10.005_bib52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"Sundar","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.idc.2018.10.005_bib53","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine","volume":"47","author":"Sundar","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2018.10.005_bib54","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","article-title":"Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial","volume":"4","author":"Hailu","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.idc.2018.10.005_bib55","doi-asserted-by":"crossref","first-page":"e855","DOI":"10.1371\/journal.pntd.0000855","article-title":"Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study","volume":"4","author":"Musa","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.idc.2018.10.005_bib56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A\u00a0comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/infdis\/jiu039","article-title":"Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure","volume":"210","author":"Dorlo","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study","volume":"80","author":"Pintado","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.idc.2018.10.005_bib59","doi-asserted-by":"crossref","first-page":"e2195","DOI":"10.1371\/journal.pntd.0002195","article-title":"Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison","volume":"7","author":"Cota","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idc.2018.10.005_bib60","unstructured":"CDC. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2013."},{"issue":"12","key":"10.1016\/j.idc.2018.10.005_bib61","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/cid\/cir674","article-title":"Limited effectiveness of high-dose liposomal amphotericin B (Ambisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence","volume":"53","author":"Ritmeijer","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.10.005_bib62","doi-asserted-by":"crossref","first-page":"e2816","DOI":"10.1371\/journal.pntd.0002816","article-title":"Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil","volume":"8","author":"Cota","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.idc.2018.10.005_bib63","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/cid\/cir521","article-title":"Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India","volume":"53","author":"Sinha","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2018.10.005_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1179\/000349803225002615","article-title":"The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV","volume":"97","author":"Lopez-Velez","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"10","key":"10.1016\/j.idc.2018.10.005_bib65","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cid\/cix607","article-title":"The risk and predictors of visceral leishmaniasis relapse in human immunodeficiency virus-coinfected patients in Ethiopia: a retrospective cohort study","volume":"65","author":"Abongomera","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.005_bib66","unstructured":"WHO. Report of the Fifth Consultative Meeting on Leishmania\/HIV Coinfection, March 20-22. Addis Ababa, Ethiopia, 22 Mar 2007."},{"issue":"10","key":"10.1016\/j.idc.2018.10.005_bib67","doi-asserted-by":"crossref","first-page":"e0004087","DOI":"10.1371\/journal.pntd.0004087","article-title":"Use of pentamidine as secondary prophylaxis to prevent visceral leishmaniasis relapse in HIV infected patients, the first twelve months of a prospective cohort study","volume":"9","author":"Diro","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.idc.2018.10.005_bib68","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/cid\/cix807","article-title":"Long-term clinical outcomes in visceral leishmaniasis-HIV co-infected patients during and after pentamidine secondary prophylaxis in Ethiopia: a single-arm clinical trial Authors and affiliations","volume":"66","author":"Diro","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2018.10.005_bib69","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1136\/annrheumdis-2011-200596","article-title":"Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats","volume":"71","author":"Bogdan","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.idc.2018.10.005_bib70","doi-asserted-by":"crossref","first-page":"e0163047","DOI":"10.1371\/journal.pone.0163047","article-title":"A\u00a0comparison of the effectiveness of sodium stibogluconate monotherapy to sodium stibogluconate and paromomycin combination for the treatment of severe post kala azar dermal leishmaniasis in South Sudan - a retrospective cohort study","volume":"11","author":"Abongomera","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.idc.2018.10.005_bib71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/cid\/ciy172","article-title":"Safety and effectiveness of short-course Ambisome in the treatment of post-kala-azar dermal leishmaniasis (PKDL): a prospective cohort study in Bangladesh","volume":"67","author":"den Boer","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.10.005_bib72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trstmh.2007.08.006","article-title":"Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment","volume":"102","author":"Musa","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9496","key":"10.1016\/j.idc.2018.10.005_bib73","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.005_bib74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","article-title":"Chemotherapy in the treatment and control of leishmaniasis","volume":"61","author":"Alvar","year":"2006","journal-title":"Adv Parasitol"},{"issue":"10","key":"10.1016\/j.idc.2018.10.005_bib75","doi-asserted-by":"crossref","first-page":"e3273","DOI":"10.1371\/journal.pntd.0003273","article-title":"IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test","volume":"8","author":"Bhattacharyya","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idc.2018.10.005_bib76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fcimb.2017.00200","article-title":"IFN-gamma, IL-2, IP-10, and MIG as biomarkers of exposure to leishmania spp., and of cure in human visceral leishmaniasis","volume":"7","author":"Ibarra-Meneses","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.idc.2018.10.005_bib77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.actatropica.2016.09.026","article-title":"Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients","volume":"164","author":"Castro","year":"2016","journal-title":"Acta Trop"},{"issue":"7571","key":"10.1016\/j.idc.2018.10.005_bib78","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.38917.503056.7C","article-title":"A\u00a0meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis","volume":"333","author":"Chappuis","year":"2006","journal-title":"BMJ"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:14:37Z","timestamp":1760195677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552018300928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0891552018300928"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2018.10.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visceral Leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}